drugset / Trial / NCT02623127
A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma
Phase 2
Completed
25 enrolled
Seoul National University Hospital
SMG-SNU Boramae Medical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
This study aims to investigate the clinical activity of sunitinib in patients with advanced thymic carcinoma who have failed chemotherapy.
Timeline
- Start
- 2015-10
- Primary completion
- 2017-12
- Completion
- 2018-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sunitinib | Small molecule | 50 mg | Oral |